Title |
Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial |
|---|---|
Involved |
Hans-Joachim Schmoll (Verfasser)
Julia Mann (Verfasser) Fabian Meinert (Verfasser) Benjamin Garlipp (Verfasser)
Kersten Borchert (Verfasser)
Arndt Vogel (Verfasser) Eray Goekkurt (Verfasser) Ulrich Kaiser (Verfasser) Heinz-Gert Hoeffkes (Verfasser) Jörn Rüssel (Verfasser) Stephan Kanzler (Verfasser) Thomas Edelmann (Verfasser) Helmut Forstbauer (Verfasser) Thomas Göhler (Verfasser) Carla Hannig (Verfasser) Bert Hildebrandt (Verfasser) Carsten Roll (Verfasser) Carsten Bokemeyer (Verfasser) Jörg Steighardt (Verfasser) Franziska Cygon (Verfasser) Stefan Ibach (Verfasser) Alexander Stein (Verfasser) Joseph Tintelnot (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
British journal of cancer : BJC 130, 2, 23.11.2023, date:2.2024, Seite 233-241 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedical Research. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024040121560594253243 (URN) |
Record ID |
1324969377 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: